Various Adverse Effects and Behaviors Associated with Sildenafil; Another Case of Glycemic Control Problems Associated with Fluoroquinolone Therapy; The First Case of Pure White Cell Aplasia in a Patient Treated with Imipenem–Cilastatin; High-Output Heart Failure Associated with Anagrelide; Renal Dysfunction Attributed to Oral Acyclovir Therapy; Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy – Reiterating the Importance of Reporting Adverse Events; A Final Note on Medication Adherence
Keyword(s):
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Keyword(s):
2012 ◽
Vol 2012
(jul09 1)
◽
pp. bcr2012006289-bcr2012006289
◽
2016 ◽
Vol 31
(12)
◽
pp. 2051
◽
Keyword(s):